JPRN-UMIN000033381已完成未知
A clinical trial for 8 continuous weeks intake of HK1502 that are solid preparations blended with vitamin. - A clinical trial for 8 continuous weeks intake of HK1502.
Kojinkai, Association of Medical Corporation Hosui General Medical Clinic.0 个研究点目标入组 23 人开始时间: 2019年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects who suffer any disease at present and who are going to take continuous medical treatments during the clinical trial, or who are going to use the over-the-counter drug. 2)Subjects who have trauma on the middle fingertip of the left hand, and who have a negative influence on the skin AGE fluorometry. 3)Subjects who have hypersensitivity or allergic reaction to a certain drug medicine or food. 4)Subjects who have an operation career such as hepatectomy, gastrectomy, gastrointestinal suturesin, intestinal resection, transplanting and others in a digestive organ. 5)Subjects who have impaired respiratory and cardiovascular organ. 6)Subjects with experience of alcoholism, or who drink liquor excessively(pure alcohol conversion : over-60g per day). 7)Subjects who have participated in other clinical trials and use tests that apply foods and others within the last 12 weeks prior to the current clinical trial. 8)Subjects who apply to the following. (1)Male subjects who donated 400ml of blood within the last 12 weeks prior to the current clinical trial. In female, within the last 16 weeks. (2)Subjects who donated 200ml of blood within the last 4 weeks prior to the current clinical trial. (3)Subjects who donated components of blood such as blood platelet and blood plasma within the last 2 weeks prior to the current clinical trial. (4)Subjects who have had experiences of a blood collecting conforming to the above matters. 9)Subjects who are the pregnant or breast-feeding woman. 10)Subjects who are planning to become the pregnant woman during the clinical trial. 11)Others who have been determined ineligible or undesirable by investigator.
研究者
相似试验
尚未招募
不适用
Clinical trial to evaluate the efficacy and safety of Gold Mae-sun therapy on degenerative knee osteoarthritisDiseases of the musculo-skeletal system and connective tissueKCT0003968Wonkwang University, Gwangju Medical Center30
招募中
Unknown
A human trial of Fermented soybean(Doenjang powder)on intestinal microflora and menopausal women's healthKCT0008958Wonkwang University Hospital60
招募中
不适用
A 8 weeks, randomized, double-blind human trial to evaluate the efficacy and safety of Fermented soybean(Cheonggukjang powder) on intestinal microflora and decrease of body fatEndocrine, nutritional and metabolic diseasesKCT0007734Wonkwang University Hospital60
尚未招募
2 期
Atorvastatin for treatment of acute inflammation in newly diagnosed children with Crohn’s diseaseCrohn's diseaseOral and Gastrointestinal - Crohn's diseaseACTRN12612000129886Royal Children's Hospital60
进行中（未招募）
1 期
An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patients with major depressive disorderEUCTR2007-003159-36-FRsanofi-aventis recherche & développement675